Combined Submyeloablative and Myeloablative Dose Intense Melphalan Results in Satisfactory Responses with Acceptable Toxicity in Patients with Multiple Myeloma-Reference-Cited by-同舟云学术

Combined Submyeloablative and Myeloablative Dose Intense Melphalan Results in Satisfactory Responses with Acceptable Toxicity in Patients with Multiple Myeloma

Published:2010-10 Issue:10 Volume:16 Page:1402-1410
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Novitzky Nicolas,Thomson Jaqueline,Thomas Valda,du Toit Cecile,Mohamed Zainab,McDonald Andrew

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma;McElwain;Lancet,1983

2. Intensive combined therapy for previously untreated aggressive myeloma;Attal;Blood,1992

3. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996

4. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

5. Thalidomide for treatment of multiple myeloma: 10 years later;Palumbo;Blood,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology, Treatment Trends, and Outcomes of Multiple Myeloma in the Middle East and Africa: A Systematic Review;Clinical Hematology International;2024-02-22

2. Cancer testis antigen MAGE C1 can be used to monitor levels of circulating malignant stem cells in the peripheral blood of multiple myeloma patients;Journal of Cancer Research and Clinical Oncology;2016-08-31

3. Autologous Stem Cell Transplantation in the Management of Multiple Myeloma;Multiple Myeloma;2013-09-04

4. Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation;European Journal of Haematology;2011-07-15